Lloyd George W.
EVP, Investments & CLO
Lloyd George W. has filed 4 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Dec 19, 2025.
On the most recent filing, Lloyd George W. is listed as EVP, Investments & CLO at Royalty Pharma plc. Inside the rolling window, Lloyd George W. reported no open-market purchases and 4 open-market sales totaling $13.8M in RPRX. The largest disclosed transaction in the window is a sale of 135,426 RPRX shares on Nov 19, 2025, worth $5.2M.
Companies traded
Other insiders at RPRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lloyd George W. made?
Lloyd George W. has filed 4 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Lloyd George W. trade?
Lloyd George W. has filed SEC Form 4 disclosures for 1 company, including RPRX.
When was Lloyd George W.'s most recent SEC Form 4 filing?
Lloyd George W.'s most recent SEC Form 4 filing on Tracefour is dated Dec 19, 2025.
What is Lloyd George W.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lloyd George W. is listed as EVP, Investments & CLO.
What is Lloyd George W.'s total buy and sell value in the current window?
Inside the rolling retention window, Lloyd George W. bought $0 and sold $13.8M based on SEC Form 4 filings.
What was Lloyd George W.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 135,426 RPRX shares on 2025-11-19, worth $5.2M, per SEC Form 4 filings.